In 2015, a senior executive at Mattel received an email from the company’s newly appointed CEO. The note requested the processing of an overdue payment to a familiar manufacturer. In acting on the email, the executive set-in motion a $3 million mistake.
Cyber attacks of this kind are known…
Source: www.finextra.com – Read more
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
